A new technique called CHANGE-seq-BE improves genome editing safety by precisely detecting hidden off-target DNA changes. This breakthrough supports safer gene therapies.
Discover CHANGE-seq-BE: Advanced Genome Editing Off-Target Detection
What Is CHANGE-seq-BE and Why Does It Matter?
CHANGE-seq-BE is a new technique that greatly improves how scientists detect off-target effects in genome editing. Unlike older methods, it precisely finds where base editors make unintended changes in DNA. This innovation helps ensure safer applications of gene editing, especially for treating genetic diseases.
How Does CHANGE-seq-BE Work?
The method starts by circularizing purified genomic DNA. Scientists then expose this circular DNA to base editor ribonucleoprotein (RNP) complexes. These editors include adenine base editors (ABEs) and cytosine base editors (CBEs), which convert specific nucleotides to repair mutations.
After editing, specialized enzymes cut the DNA at edited points. This step allows researchers to selectively sequence only the modified DNA segments. As a result, sensitive and unbiased detection of both on-target and off-target editing becomes possible in one streamlined process.
The Importance of Identifying Off-Target Activity in Genome Editing
Genome editing tools can sometimes make changes at unintended sites. This raises safety concerns for clinical applications. Thus, using unbiased methods like CHANGE-seq-BE plays a crucial role in assessing risks before therapies reach patients.
This approach identified off-target sites missed by previous techniques. For example, researchers found that an adenine base editor (ABE8e) showed more off-target activity than Cas9 nuclease targeting the same gene. Such findings highlight why detecting off-target edits accurately matters deeply for gene therapy development.
CHANGE-seq-BE enables clinical researchers to precisely monitor unintended edits with unprecedented sensitivity, says Dr. David Liu, a pioneer in genome editing technologies.
The Role of CHANGE-seq-BE in Clinical Gene Therapy
This method supported genotoxicity studies for an emergency investigational new drug application targeting X-linked hyper IgM syndrome using ABE technology. It proved critical in validating both efficacy and safety within human cells before treatment advancement.
Future Prospects: Safer and More Effective Gene Editing
By improving detection of no-go spots during editing;, scientists can now better design highly specific base editors with minimal side effects. Ultimately, this means safer therapies and broader medical use ranging from inherited disease correction to cancer treatments.
Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Also, at ENTECH Online, you’ll find a wealth of information.
Reference
- Lazzarotto, C. R., Katta, V., Li, Y., Manquen, G., Wood, R. K., Chyr, J., Urbina, E., Matsubara, A., Lee, G., Wu, X., De Ravin, S. S., & Tsai, S. Q. (2026). Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE. Nature Biotechnology. https://doi.org/10.1038/s41587-025-02948-7
- Author
- Latest Posts
Ashwini Kshirsagar holds a graduate degree in Chemistry and a postgraduate degree in Environmental Science from Shivaji University, Kolhapur. With a strong foundation in scientific principles and a creative flair, she blends her expertise in environmental science with skills in technical writing, graphic design, and video editing. Proficient in Adobe software, Ashwini excels at transforming complex scientific concepts into clear, engaging, and visually compelling content. Her unique ability to merge science and storytelling allows her to create impactful communication materials that are both informative and accessible to a wide audience.
